285 related articles for article (PubMed ID: 30973702)
1. pH-Responsive Nanoparticles Targeted to Lungs for Improved Therapy of Acute Lung Inflammation/Injury.
Zhang CY; Lin W; Gao J; Shi X; Davaritouchaee M; Nielsen AE; Mancini RJ; Wang Z
ACS Appl Mater Interfaces; 2019 May; 11(18):16380-16390. PubMed ID: 30973702
[TBL] [Abstract][Full Text] [Related]
2. Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy.
Li SJ; Wang XJ; Hu JB; Kang XQ; Chen L; Xu XL; Ying XY; Jiang SP; Du YZ
Drug Deliv; 2017 Nov; 24(1):402-413. PubMed ID: 28165814
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of tea polyphenol-loaded nanoparticles coated with platelet membranes on LPS-induced lung injury.
Jin H; Zhao Y; Yao Y; Zhao J; Luo R; Fan S; Wei Y; Ouyang S; Peng W; Zhang Y; Pi J; Huang G
Biomater Sci; 2023 Sep; 11(18):6223-6235. PubMed ID: 37529873
[TBL] [Abstract][Full Text] [Related]
4. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy.
Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ
J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254
[TBL] [Abstract][Full Text] [Related]
5. Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS).
Shah D; Das P; Acharya S; Agarwal B; Christensen DJ; Robertson SM; Bhandari V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806560
[TBL] [Abstract][Full Text] [Related]
6. Size-dependent anti-inflammatory activity of a peptide-gold nanoparticle hybrid in vitro and in a mouse model of acute lung injury.
Gao W; Wang Y; Xiong Y; Sun L; Wang L; Wang K; Lu HY; Bao A; Turvey SE; Li Q; Yang H
Acta Biomater; 2019 Feb; 85():203-217. PubMed ID: 30597258
[TBL] [Abstract][Full Text] [Related]
7. Combined delivery of angiopoietin-1 gene and simvastatin mediated by anti-intercellular adhesion molecule-1 antibody-conjugated ternary nanoparticles for acute lung injury therapy.
Jiang S; Li S; Hu J; Xu X; Wang X; Kang X; Qi J; Lu X; Wu J; Du Y; Xiao Y
Nanomedicine; 2019 Jan; 15(1):25-36. PubMed ID: 30193816
[TBL] [Abstract][Full Text] [Related]
8. ICAM-1 targeted and ROS-responsive nanoparticles for the treatment of acute lung injury.
Ran Y; Yin S; Xie P; Liu Y; Wang Y; Yin Z
Nanoscale; 2024 Jan; 16(4):1983-1998. PubMed ID: 38189459
[TBL] [Abstract][Full Text] [Related]
9. Layer-by-layer coated hybrid nanoparticles with pH-sensitivity for drug delivery to treat acute lung infection.
Luo J; Li X; Dong S; Zhu P; Liu W; Zhang S; Du J
Drug Deliv; 2021 Dec; 28(1):2460-2468. PubMed ID: 34766544
[TBL] [Abstract][Full Text] [Related]
10. Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study.
Fang CL; Wen CJ; Aljuffali IA; Sung CT; Huang CL; Fang JY
J Control Release; 2015 Sep; 213():69-78. PubMed ID: 26164036
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-oxidant and anti-inflammatory effects of ceria/resatorvid co-decorated nanoparticles for acute lung injury therapy.
Wu Y; Zhang Y; Tang X; Ye S; Shao J; Tu L; Pan J; Chen L; Liang G; Yin L
J Nanobiotechnology; 2023 Dec; 21(1):502. PubMed ID: 38129906
[TBL] [Abstract][Full Text] [Related]
12. E-Selectin-Binding Peptide-Modified Bovine Serum Albumin Nanoparticles for the Treatment of Acute Lung Injury.
Liu Y; Yang B; Zhao X; Xi M; Yin Z
AAPS PharmSciTech; 2019 Jul; 20(7):270. PubMed ID: 31363872
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury.
Li D; Ren W; Jiang Z; Zhu L
Mol Med Rep; 2018 Nov; 18(5):4399-4409. PubMed ID: 30152849
[TBL] [Abstract][Full Text] [Related]
14. Cell membrane-formed nanovesicles for disease-targeted delivery.
Gao J; Chu D; Wang Z
J Control Release; 2016 Feb; 224():208-216. PubMed ID: 26778696
[TBL] [Abstract][Full Text] [Related]
15. [The influence of pre-B-cell colony enhancing factor on adhesive molecule in pulmonary cells in rats with acute lung injury/acute respiratory distress syndrome].
Liu C; Zhang H; Cheng PY; Zhou FC
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Mar; 25(3):159-63. PubMed ID: 23656769
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-modulating nanoparticles for pneumonia therapy.
Muhammad W; Zhai Z; Wang S; Gao C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1763. PubMed ID: 34713969
[TBL] [Abstract][Full Text] [Related]
17. Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung.
Wang L; Rao Y; Liu X; Sun L; Gong J; Zhang H; Shen L; Bao A; Yang H
J Nanobiotechnology; 2021 Feb; 19(1):56. PubMed ID: 33632244
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome.
Marik PE; Meduri GU; Rocco PR; Annane D
Crit Care Clin; 2011 Jul; 27(3):589-607. PubMed ID: 21742218
[TBL] [Abstract][Full Text] [Related]
19. Sulphur dioxide suppresses inflammatory response by sulphenylating NF-κB p65 at Cys
Chen S; Huang Y; Liu Z; Yu W; Zhang H; Li K; Yu X; Tang C; Zhao B; Du J; Jin H
Clin Sci (Lond); 2017 Nov; 131(21):2655-2670. PubMed ID: 28935810
[TBL] [Abstract][Full Text] [Related]
20. Characterization of inflammation in a rat model of acute lung injury after repeated pulmonary lavage.
Menk M; Graw JA; Steinkraus H; Haefen Cv; Sifringer M; Spies CD; Lachmann B; Schwaiberger D
Exp Lung Res; 2015; 41(8):466-76. PubMed ID: 26381719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
